Answer
A validated test must confirm BRAF V600E mutation when cetuximab is being considered with encorafenib for previously treated metastatic colorectal cancer.
Sources for this answer
- Erbitux 5mg/ml solution for infusion — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.